Analogic Corporation (Nasdaq:ALOG), enabling the world's medical imaging and aviation security technology, announced today that it will demonstrate its industry-leading BK Medical-branded Flex Focus(TM) 500 ultrasound system with Quantum Technology(TM) and the Ultrasonix-branded SonixTablet(TM) with GPS needle guidance, at the 38th Annual Scientific Meeting of the Society of Interventional Radiology (SIR) in New Orleans, April 13--18.

Elekta recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA), allowing the company to begin shipping and installation of all components of the Versa HD™ system within the United States.

Matakina International today announced the installation of Volpara objective breast density measurement software at Jacobi Medical Center (Jacobi) and North Central Bronx Hospital (NCBH), which comprise the North Bronx Healthcare Network.

Manhattan Scientifics (MHTX: OTCQB) announced today that it has received the initial $1 million of a $2.5 million commitment to build the first generation of its advanced cancer detection devices. More information can be found in the company’s recent 8-K filing.

A new genetically engineered lab rat that has the full array of brain changes associated with Alzheimer's disease supports the idea that increases in a molecule called beta-amyloid in the brain causes the disease, according to a study, published in the Journal of Neuroscience.

Featuring a revolutionary combination of speed and accuracy, Elekta’s new Versa HD™ system will help clinicians at The Christie NHS Foundation Trust (Withington, Manchester) maximize the precision of therapeutic beams on the tumor target, while also accelerating radiation delivery to new levels.

Eli Lilly and Company (NYSE: LLY) unveiled data from four key molecules that represent the next generation of its oncology pipeline at the American Association for Cancer Research (AACR) Annual Meeting held in Washington, D.C. from April 6-10.

Scientists at the ATR Computation Neuroscience Laboratories in Kyoto, Japan, have found a way to predict what a person is dreaming about based on fMRI scans of dreamers.